NCRE-PAD Logo

Academic Publications


Almeida OP, Hankey GJ, Yeap BB, Golledge J, Flicker L. Depression as a Risk Factor for Cognitive Impairment in Later Life: The Health In Men Cohort Study. International Journal of Geriatric Psychiatry.2015: (In Press)

Omer SM, Krishna SM, Li J, Moxon JV, Nsengiyumva V, Golledge J. The efficacy of extraembryonic stem cells in improving blood flow within animal models of lower limb ischaemia. Heart.2015: (In Press)

Golledge J, Cooper ME, Chair Z. Diabetes and aortic aneurysm. Angiology.2015: (In Press)

Smith RK, Quigley F, Tosenovsky P, Velu R, Bradshaw B, Buettner P, Golledge J. Serum homocysteine is associated with the severity of primary chronic venous disease. Phlebology.2015: (In Press)

Krishna SM, Omer SM, Golledge J. Evaluation of the clinical relevance and limitations of current preclinical models of peripheral artery disease. Clinical Science.2015: (In Press)

Almeida OP, McCaul K, Hankey G, Bu Y, Golledge J, Flicker L. Excessive Alcohol Consumption Increases Mortality in Later Life: A Genetic Analysis of the Health In Men Cohort Study. Addiction Biology.2015: (In Press)

Forda AH, Yeap BB, Flicker L, Hankey GJ, Chubb SAP, Handelsman DJ, Golledge J, Almeida OP. Testosterone and Incident Depression in Older Men: The Health In Men Study. Psychoneuroendocrinology.2015: (In Press)

Emeto TI, Moxon JV, Au M, Golledge J. Oxidative stress and abdominal aortic aneurysm: Potential treatment targets. Clinical Science.2015: (In Press)

Hinchliffe RJ, Brownrigg JR, Apelqvist J, Boyko EJ, Fitridge R, Mills JL, Reekers J, Shearman CP, Zierler RE, Schaper NC. IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. Diabetes Metab Res Rev. 2015 Sep 2.

Hinchliffe RJ, Brownrigg JR, Andros G, Apelqvist J, Boyko EJ, Fitridge R, Mills JL, Reekers J, Shearman CP, Zierler RE, Schaper NC. Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. Diabetes Metab Res Rev. 2015 Sep 5.

Dreyer RP, van Zitteren M, Beltrame JF, Fitridge R, Denollet J, Vriens PW, Spertus JA, Smolderen KG. Gender differences in health status and adverse outcomes among patients with peripheral arterial disease.  Am Heart Assoc. 2015 Jan;4:e000863.

Brownrigg JR, Hinchliffe RJ, Apelqvist J, Boyko EJ, Fitridge R, Mills JL, Reekers J, Shearman CP, Zierler RE, Schaper NC. Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: a systematic review. Diabetes Metab Res Rev. 2015 Sep 5.

Brownrigg JR, Hinchliffe RJ, Apelqvist J, Boyko EJ, Fitridge R, Mills JL, Reekers J, Shearman CP, Zierler RE, Schaper NC. Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: a systematic review. Diabetes Metab Res Rev. 2015 Sep 5. 

Biros E, Moran CS, Norman PE, Hankey GJ, Yeap BB, Almeida OP, Flicker L, White R, Jones R, Golledge J. Association between the advanced glycosylation end product-specific receptor gene and cardiovascular death in older men. Plos One.2015:10(7)e0134475

Krishna SM, Seto SW, Jose RJ, Biros E, Moran CS, Wang Y, Clancy P,  Golledge J. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E deficient mouse. Arteriosclerosis, Thrombosis and Vascular Biology.2015:35(2)389-98

Almeida OP, Hankey GJ, Yeap BB, Golledge J, Norman PE, Flicker L. Depression, frailty and all cause mortality: A cohort study of men older than 75 years. Journal of the American Medical Directors Association..2015:16(4)296-300.

Majersik JJ, Cole JW, Golledge J, Rost NS, Chan YY, Gurol ME, Lindgren AG, Woo D, Israel Fernandez-Cadenas I, Chen DT, Thijs V, Worrall BB, Kamal A, Bentley P, Wardlaw JM, Ruigrok YM, Battey TWK, Schmidt R, Montaner J, Giese AK, Roquer J, Jiménez-Conde J, Lee C, Ay H, Martin JJ, Rosand J, Maguire J, On behalf of the International Stroke Genetics Consortium. Recommendations from the International Stroke Genetics Consortium, Part 1: Standardized Phenotypic Data Collection. Stroke.2015:46(1)279-84

Ford AH,  Flicker L,  Hankey GJ, Yeap BB, Chubb SAP, Golledge J, Almeida OP. Insulin Resistance and Depressive Symptoms in Older Men: The Health in Men Study. The American Journal of Geriatric Psychiatry.2015:23(8)872-80

Yeap BB, McCaul KA, Flicker L, Hankey GJ, Almeida OP, Golledge J, Norman PE. Diabetes, myocardial infarction and stroke are distinct and duration-dependent predictors of subsequent cardiovascular events and all-cause mortality in older men. The Journal of Clinical Endocrinology and Metabolism.2015:100(3)1038-47

Chubb SAP, Byrnes E, Manning L, Beilby JP, Ebeling PR, Vasikaran SD, Golledge J, Flicker L, Yeap BB. Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health In Men Study. The Journal of Clinical Endocrinology and Metabolism.2015:100(1)90-9

Leicht A, Crowther R, Golledge J. Influence of regular exercise on body fat and eating patterns of patients with intermittent claudication. International Journal of Molecular Sciences.2015:16(5)11339-54

Krishna SM, Trollope A, Golledge J. The relevance of epigenetics to occlusive cerebral and peripheral arterial disease. Clinical Science.2015:128(9)537-58

Almeida OP, Hankey, Yeap BB, Golledge J, Flicker L. Prevalence, associated factors, mood and cognitive outcomes of traumatic brain injury in later life: The Health In Men Study (HIMS). International Journal of Geriatric Psychiatry.2015:30 1215-23

Almeida OP, Hankey GJ, Yeap BB, Golledge J, Flicker L. Vitamin D concentration and its association with past, current and future depression in older men: the Health In Men Study. Maturitas.2015:81 36-41

Krishna SM, Moxon J, Golledge J. A review of the pathophysiology and potential biomarkers for peripheral arterial disease. International Journal of Molecular Sciences.2015:16(5)11294-322

Almeida OP, Yeap BB, Hankey GJ, Golledge J, Flicker L. Association of depression with sexual and daily activities: A community study of ocotogenarian men. American Journal of Geriatric Psychiatry.2015:23(3)234-42

McCaul KA, Almeida OP, Norman PE, Yeap BB, Hankey GJ, Golledge J, Flicker L.. How Many Older People Are Frail? Using Multiple Imputation to Investigate Frailty in the Population. Journal of the American Medical Directors Association.2015:16(5)439-e1-7

Sahebkar A, Simental-Mendia LE, Golledge J, Watts GF. Efficacy and safety of evacetrapib for modifying plasma lipids: A systematic review and meta-analysis of randomized controlled trials. Diabetes, Obesity and Metabolism.2015:17(11)1042-55

Moxon JV,  Behl-Gilhotra R,  Morton SK,  Krishna SM,  Seto SW, Biros E, Nataatmadja M, West M, Walker PJ, Norman PE,  Golledge J. Plasma low-density lipoprotein receptor-related protein 1 concentration is not associated with human abdominal aortic aneurysm presence. European Journal of Vascular and Endovascular Surgery.2015:50(4)466-73

Hendy K, Gunnarsson R, Cronin O, Golledge J. Infra-renal abdominal aortic calcification volume does not predict small abdominal aortic aneurysm growth. Atherosclerosis.2015:243(1)334-38

Sahebkar A, Simental-Mendia LE, Watts GF, Golledge J. Impact of fibrate therapy on plasma plasminogen activator inhibitor-1: A systematic review and meta-analysis of randomized controlled trials. Atherosclerosis.2015:240(1)284-96

Abbott AL, Paraskevas KI, Kakkos SK, Golledge J, Eckstein HH, Diaz-Sandoval LJ, Cao L, Fu Q, Wijeratne T, Leung TW, Montero-Baker M, Lee BC, Pircher S, Bosch M, Dennekamp M, Ringleb P. A systematic review of guidelines for the management of asymptomatic and symptomatic carotid stenosis. Stroke.2015:46(11)3288-301

Moxon JV, Golledge J. The need for translational research to advance peripheral artery disease management. International Journal of Molecular Sciences.2015:16(5)11125-30

Ng E, Morris DR, Golledge J. The association between plasma matrix metalloproteinase-9 concentration and endoleak after endovascular aortic aneurysm repair: A meta-analysis. Atherosclerosis.2015:242(2)535-42

Yeap BB, Alfonso H, Chubb SAP, Byrnes E, Beilby JP, Ebeling PR, Allan CA, Schultz C, Hankey GJ, Golledge J, Flicker L, Norman PE. Proportion of undercarboxylated osteocalcin and serum P1NP predict incidence of myocardial infarction in older men. The Journal of Clinical Endocrinology and Metabolism.2015:100(10)3964-42

Biros E, Gabor G, Moran CS, Schreurs C, Lindeman JHN, Walker PJ, Nataatmadja M, West M, Holdt L, Hinterseher I, Pilarsky C,  Golledge J. Differential gene expression in human abdominal aortic aneurysm and aortic occlusive disease. Oncotarget.2015:30(6)12984-96

Morris DR, Cunningham MA, Ahimastos AA, Kingwell BA, Pappas E,  Bourke M,  Reid CM, Stijnen T, Dalman RL, Oliver O. Aalami OO, Lindeman JH, Norman PE, Walker PJ, Fitridge R, Bourke B, Dear AE, Pinchbeck J, Jaeggi R, Golledge J. TElmisartan in the management of abDominal aortic aneurysm (TEDY): Study protocol for a randomized controlled trial. Trials.2015: 16(1)274

Smout MJ, Sotillo J, Laha T, Papatpremsiri A, Rinaldi G, Chan LY, Johnson M, Turnbull L, Whitchurch C, Giacomin PR, Moran C, Golledge J, Daly N, Sripa B, Mulvenna JP, Brindley PJ, Loukas A. Carcinogenic parasite secretes growth factor that accelerates wound healing and potentially promotes neoplasia. PLOS Pathogens.2015:11(10)e1005209

Nsengiyumva V, Fernando ME, Moxon JV, Krishna SM, Pinchbeck J, Omer SM, Morris DR, Jones RE, Moran CS, Seto SW, Golledge J. The association of circulating 25-hydroxyvitamin D concentration with peripheral arterial disease: A meta-analysis of observational studies. Atherosclerosis.2015:243(2)645-651

Fernando ME, Crowther RG, Cunningham M, Lazzarini PA,  Sangla KS, Golledge J. Lower limb biomechanical characteristics of patients with neuropathic diabetic foot ulcers: The diabetes foot ulcer study protocol. BMC Endocrine Disorders.2015:15(1)59

Sahebkar A, Simental-Mendía LE, Ferretti G, Bacchetti T, Golledge J. Statin therapy and plasma vitamin E concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials. Atherosclerosis.2015:243(2)579-88

Baba M, Davis WA, Norman PE, Davis TME. Temporal changes in the prevalence and associates of foot ulceration in type 2 diabetes: The Fremantle Diabetes Study. Diab Compl 2015: 29:356-61. 

Kurowski JR, Nedkoff L, Schoen DE, Knuiman M, Norman PE, Briffa TG. Temporal trends in initial and recurrent lower extremity amputations in people with and without diabetes in Western Australia from 2000 to 2010. Diab Res Clin Pract 2015;108:280-7. 

Doyle B, Sun Z, Jansen S, Norman P. Computational modeling of contemporary stent-grafts. Endovasc Ther 2015;22:591-593 

Medbury HJ, Williams H, Li S, Fletcher JP.  The bidirectional relationship between cholesterol and macrophage polarization.  J Clin Cell Immunol 2015; 6:303. doi: 10.4172/2155-9899.1000303. 

Doyle B, Norman P. Computational biomechanics in thoracic aortic dissection: today's approaches and tomorrow's opportunities. Ann Biomed Eng (accepted for publication 7/6/15). 

Morris DR, Moxon JV, Golledge J. Letter by Morris et al Regarding Article, Improved Quality of Life After 1 Year With an Invasive Versus a Noninvasive Treatment Strategy in Claudicants: One-Year Results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation.2015:

Leicht AS, Parmenter BJ. Exercise for improving management of peripheral arterial disease. Cardiology Today.2014:4(4)21-24

Ademi Z, Liew D, Gorelik A, Bohensky M, Zomer E, Hollingsworth B, Steg G, Bhatt DL, Reid CM on behalf of the REACH Registry investigators. Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data.  International Journal of Cardiology, 2014: Jul 15 175(1):72-7 http://dx.doi.org/10.1016/j.ijcard.2014.04.230 IF: 7.087 

Ruzehaji N, Kopecki Z, Melville E, Appleby SL, Bonder CS, Arkell RM, Fitridge R, Cowin AJ. Attenuation of flightless I improves wound healing and enhances angiogenesis in a murine model of type 1 diabetes. Diabetologia. 2014 Feb;57:402-12

Mehmood N, Hariz A, Fitridge R, Voelcker NH. Applications of modern sensors and wireless technology in effective wound management. J Biomed Mater Res B Appl Biomater. 2014 May;102:885-95. 

Almeida OP, Ford AH, Flicker L, Hankey GJ, Yeap BB, Clancy P, Golledge J. Angiogenesis inhibition and depression in older men. Journal of Psychiatry and Neuroscience.2014:39(3)200-5

Almeida OP, Hankey GJ, Yeap BB, Golledge J, Flicker L. The triangular association of ADH1B genetic polymorphism, alcohol consumption and the risk of depression in older men. Molecular Psychiatry.2014:19 995-1000

Askew CD, Parmenter B, Leight AS, Walker PJ, Golledge J. Exercise prescription for patients with peripheral arterial disease and intermittent claudication: A position statement from Exercise & Sports Science Australia. Journal of Science and Medicine in Sport.2014:17(6)623-9

Almeida OP, Yeap BB, Hankey GJ, Golledge J, Flicker L. HDL cholesterol and the risk of depression over 5 years. Molecular Psychiatry.2014:19(6)637-8

Golledge J, Ewels C, Muller R, Walker PJ. Association of chronic kidney disease categories defined with different formulae with major adverse events in patients with peripheral vascular disease. Atherosclerosis.2014:232(2)289-97

Yeap BB, Alfonso H, Chubb P, Handelsman DJ, Hankey GJ, Almeida OP, Golledge J, Norman PE, Flicker L.. In older men an optimal plasma testosterone is associated with reduced all-cause mortality, and higher dihydrotestosterone with reduced ischaemic heart disease mortality, while estradiol levels do not predict mortality. The Journal of Clinical Endocrinology and Metabolism.2014:99(1)E9-E18

Emeto TI, Moxon JV, Biros E, Rush CM, Clancy P, Woodward L, Moran CS, Jose RJ, Nguyen T, Walker PJ, Golledge J. Urocortin 2 is associated with abdominal aortic aneurysm and mediates anti-proliferative effects on vascular smooth muscle cells via corticotrophin releasing factor receptor 2. Clinical Science.2014:126(7)517-27

Golledge J, Clancy P, Maguire J, Lincz L, Koblar S, McEvoy M, Attia J, Levi C, Sturm J, Almeida OP, Yeap BB, Flicker L, Norman P, Hankey GJ. Plasma angiopoietin-1 is lower after ischemic stroke and associated with major disability but not stroke incidence. Stroke.2014:45(4)1064-8

Hendy K, Gunnarson R, Golledge J. Growth rates of small abdominal aortic aneurysms assessed by computerised tomography - A systematic literature review. Atherosclerosis.2014:235(1)182-8

Moran CS, Jose RJ, Biros E, Golledge J. Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse. Arteriosclerosis, Thrombosis and Vascular Biology.2014:34(12)2609-16

Neuen BL, Gunnarsson R, Webster AC, Baer RA. Factors associated with patency following angioplasty of hemodialysis fistulas. Journal of Vascular and Interventional Radiology.2014:25(9)1419-26

Yeap BB, McCaul KA, Flicker L, Hankey GJ, Almeida OP, Golledge J, Norman PE. In older men, higher plasma testosterone or dihydrotestosterone are independent predictors for reduced incidence of stroke but not myocardial infarction. The Journal of Clinical Endocrinology and Metabolism.2014:99(12)4565-73

Clancy P, Koblar SA, Golledge J. Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation. Atherosclerosis.2014:236(1)108-15

Golledge J, Quigley F, Velu R, Walker PJ, Moxon J. Association of impaired fasting glucose diabetes and their management with the presentation and outcome of peripheral artery disease: A cohort study. Cardiovascular Diabetology.2014:9(6)e99954

Wong YYE, Hyde Z, McCaul KA, Yeap BB, Golledge J, Hankey GJ, Flicker L. In older men, lower plasma 25-hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancer. Plos One.2014:9(6)e99954

Golledge J, Hankey GJ, Yeap BB, Almeids OP, Flicker L, Norman PE. Reported high salt intake is associated with increased prevalence of abdominal aortic aneurysm and larger aortic diameter in older men Plos One:2014: 9(7)e102578

Morris DR, Rodriguez AJ, Moxon JV, Cunningham MA, McDermott MM, Myers J, Leeper NJ, Jones RE, Golledge J. The association of lower extremity performance with cardiovascular and all-cause mortality in patients with peripheral artery disease: A systematic review and meta-analysis. JAHA: Journal of the American Heart Association.2014:3(4)pii:e001105

Wang Y, Emeto TI, Lee J, Marshman L, Moran C, Seto Sai-Wang, Golledge J. Mouse models of intracranial aneurysm. Brain Pathology.2014:15(9)860-73

Emeto TI, Seto SW, Golledge J. Targets for medical therapy to limit abdominal aortic aneurysm progression. Current Drug Targets.2014:15(9)860-73

Wang Y, Golledge J. Angiotensin II, sympathetic nerve activity and chronic heart failure. Heart Failure Reviews.2014:19(2)187-98

Clancy P, Lisa FL, Maguire J, McEvoy M, Koblar SA, Golledge J. Tenascin-C is increased in atherothrombotic stroke patients and has an anti-inflammatory effect in the human carotid artery. BioFactors.2014:126(11)795-803

Biros E, Moran CS, Wang Y, Walker PJ, Cardinal J, Golledge J. MicroRNA profiling in patients with abdominal aortic aneurysms: the significance of miR-155. Clinical Science.2014:126(11)795-803

Golledge J, Clancy P, Hankey GJ, Yeap BB, Norman PE. Serum endostatin concentrations are higher in men with symptoms of intermittent claudication. Disease Markers.2014:2014 298239

Moxon JV, D Liu D, Wong G, Weir JM, Behl-Gilhotra R, Bradshaw B, Kingwell BA, Meikle PJ, Golledge J. Comparison of the serum lipidome in patients with abdominal aortic aneurysm and peripheral artery disease. Circulation: Cardiovascular Genetics.2014:7(1)71-79

Biros E, Moran CS, Rush CM, Gäbel G, Schreurs C, Lindeman JHN,  Walker PJ, Nataatmadja M, West M, Holdt LM, Hinterseher I, Pilarsky C, Golledge J. Differential gene expression in the proximal neck of human abdominal aortic aneurysm. Atherosclerosis.2014:233(1)211-8

Almeida OP, Hankey GJ, Yeap BB, Golledge J, Flicker L. Alcohol Consumption and Cognitive Impairment in Older Men: a Mendelian Randomisation Study. Neurology.2014:82(12)1038-44

Martin D, Wallace D, Crowe M, Rush C, Tosenovsky P, Golledge J. Association of total white cell count with mortality and major adverse events in patients with peripheral arterial disease: A systematic review. European Journal of Vascular and Endovascular Surgery.2014:47(4)422-32

Moxon JV, Liu D, Moran CS, Crossman DJ, Krishna SM, Yonglitthipagon P, Emeto TI, Morris DR, Padula MP, Mulvenna JP, Rush CM, Golledge J. Proteomic and genomic analyses suggest the association of Apolipoprotein C1 with abdominal aortic aneurysm. Proteomics Clinical Applications.2014:8(10)762-72

Almeida OP, Hankey GJ, Yeap BB, Golledge J, Norman PE, Flicker L. Mortality among People with Severe Mental Disorders Who Reach Old Age: A Longitudinal Study of a Community-Representative Sample of 37892 Men. Plos One.2014:9(10)e111882

Rai D, Wisniowski B, Bradshaw B, Velu R, Tosenovsky P, Quigley F, Walker PJ, Golledge J. Abdominal aortic aneurysm calcification and thrombus volume are not associated with outcome following endovascular abdominal aortic aneurysm repair. European Radiology.2014:24(8)1768-76

Khosla S, Morris DR, Moxon JV, Walker PJ, Gasser TC, Golledge J. Comparison of peak wall stress in ruptured, symptomatic and intact abdominal aortic aneurysms: A systematic review and meta-analysis. British Journal of Surgery.2014:101(11)1350-7

Wang Y, Krishna SM, Moxon J, Dinh TN, Jose RJ, Yu H, Golledge J. Influence of apolipoprotein E, age and aortic site on calcium phosphate induced abdominal aortic aneurysm in mice. Atherosclerosis.2014:235(1)204-12

Neuen BL, Gunnarsson R, Baer RA, Tosenovsky P, Golledge, J, Mantha ML.. Predictors of patency after balloon angioplasty in hemodialysis fistulas: A systematic review. Journal of Vascular and Interventional Radiology.2014:25(6)917-24

Biros E, Moran CS, Walker PJ, Cardinal J, Golledge J. A deletion in chromosome 6q is associated with human abdominal aortic aneurysm. Clinical Science2014:127(7)475-84

Fernando ME, Crowther RG, Pappas E, Lazzarini PA,  Cunningham M, Sangla KS, Buttner PG, Golledge J. Plantar pressure in diabetic peripheral neuropathy patients with active foot ulceration, previous ulceration and no history of ulceration: A meta-analysis of observational studies. Plos One.2014:9(6)e99050

Smith RK, Golledge J. A systematic review of circulating markers in primary chronic venous insufficiency. Phlebology.2014:29(9)570-9

Morris DR, Biros E, Cronin O, Kuivaniemi H, Golledge J. The association of genetic variants of matrix metalloproteinases with abdominal aortic aneurysm: A systematic review and meta-analysis. Heart.2014:100(4)295-302

Golledge J. Abdominal aortic calcification: Clinical significance, mechanisms and therapies. Current Pharmaceutical Design.2014:20(37)5834-8

Almeida OP, Khan KM, Hankey GJ, Yeap BB, Golledge J, Flicker L. 150 Minutes of Moderate to Vigorous Physical Activity per Week Predicts Survival and Successful Ageing: A Population-Based 11-Year Longitudinal Study of 12201 Older Australian Men. British Journal of Sports Medicine.2014:48(1)220-5

Golledge J, Iyer V, Jenkins J, Bradshaw B, Cronin O, Walker PJ. Thrombus volume is similar in patients with ruptured and intact abdominal aortic aneurysms. Journal of Vascular Surgery.2014:59(2)315-20

Rahmatzadeh M, Perlmutter P, Gaspari T, Liu HB, Hu Y, Welungoda I, Widdop RE, and Dear AE. A Novel Agent with Histone Deacetylase Inhibitory Activity Attenuates Neointimal Hyperplasia. Cardiovascular Drugs and Therapy.2014: 28:395-406

Sampson UKA, Norman PE, Fowkes GR, Aboyans V, Song Y, Harrell Jr FE, Forouzanfar MH, Naghavi M, Denenberg JO, McDermott MM, Criqui MH, Mensah GA, Ezzati M, Murray C. Estimation of global and regional incidence and prevalence of abdominal aortic aneurysms 1990 to 2010. Global Heart 2014 9:159-170. 

Medbury HJ, Williams H, Fletcher JP.  Clinical significance of macrophage phenotypes in cardiovascular disease.  Clinical and Translational Medicine 2014; 3:42.

Williams MWY, Guiffre AK, Fletcher JP.  Platelets and smooth muscle cells affecting the differentiation of monocytes.  PLoS ONE 2014; 9(2): e88172. doi:10.1371/journal.pone.0088172

Norman PE, Powell, JT. Vitamin D and cardiovascular disease. Circ Res 2014;114:379-93

Doyle BJ, McGloughlin TM, Miller K, Powell JT, Norman PE. Finite element analysis accurately predicts the location of rupture in abdominal aortic aneurysm. CardioVasc Intervent Radiol (accepted for publication 2/2/14). 

Jamrozik E, Hyde Z, Alfonso H, Flicker L, Almeida OP, Yeap BB, Norman P, Hankey GJ, Jamrozik K. The validity of self-reported versus hospital-coded diagnosis of stroke – a cross sectional and longitudinal study. Cerebrovasc Dis 2014; 37:256-262 

FGR Fowkes FGR, Murray GD, Butcher I, Folsom AR, Hirsch AT, Couper DJ, DeBacker G, Kornitzer M, Newman AB, Sutton-Tyrrell KC, Cushman M, Lee AJ, Price JF, D’Agostino, Sr RB, Murabito JM, Norman PE, Masaki KH, Bouter LM, Heine RJ, Stehouwer CDA, McDermott1 MM, Stoffers HEJH, Knottnerus JA, Ogren M, Hedblad B, Koenig W, Meisinger C, Cauley JA, Franco OH, Hunink MGM, Hofman A, Witteman JC, Criqui MH, Langer RD, Hiatt WR, Hamman RF Ankle Brachial Index Collaboration. Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. Eur J Prev Cardiol 2014;21:310-20.

Sampson UKA, Norman PE, Fowkes GR, Aboyans V, Song Y, Harrell Jr FE, Forouzanfar MH, Naghavi M, Denenberg JO, McDermott MM, Criqui MH, Mensah GA, Ezzati M, Murray C. Global and regional burden of aortic dissection and aneurysms mortality trends in 21 world regions, 1990 to 2010. Global Heart 2014:9:171-180.

Sampson UKA, Fowkes GR, McDermott MM, Criqui MH, Aboyans V, Norman PE, Forouzanfar MH, Naghavi M, Song Y, Harrell Jr FE, Denenberg JO, Mensah GA, Ezzati M, Murray C. Global and regional burden of death and disability from peripheral artery disease in 21 World Regions, 1990 to 2010. Global Heart 2014;9:145-158. 

Schoen DE, Norman PE. Diabetic foot disease in Indigenous people. Diabetes Manage 2014;4:489-500. 

Ademi Z, Huq M, Liew D, Steg G, Bhatt DL, Nelson MR,  Reid CM. on behalf of the Australian REACH registry. The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry. Cardiovasc Ther.  2013: Dec; 31(6):370-6  doi: 10.1111/1755-5922.12034  IF: 2.891 

Ademi Z, Liew D, Zomer E, Gorelik A, Hollingsworth B, Steg PG, Bhatt DL, Reid CM. Outcomes and excess costs among patients with cardiovascular disease. Heart, Lung Circ. 2013: Sep;22(9):724 - 30  IF: 1.254 

Ademi Z, Liew D, Hollingsworth B, Steg PG, Bhatt DL, Reid CM on behalf of the REACH Registry Australian cohort.  Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian cohort. Cardiovasc Ther 2013 Feb;31(1):45-52. doi: 10.1111/j.1755-5922.2011.00291.x.  IF: 2.183 

Medbury HJ, James V, Ngo J, Hitos K, Wang Y, Harris DC, Fletcher JP.  Differing association of macrophage subsets with atherosclerotic plaque stability.   Int Angiol 2013; 32, 74-84 

Wright N, Fitridge R. Varicose veins - Natural history, assessment and management. Aust Fam Physician. 2013 Jun;42:380-4.

Ruzehaji N, Mills SJ, Melville E, Arkell R, Fitridge R, Cowin AJ. The influence of Flightless I on Toll-like-receptor-mediated inflammation in a murine model of diabetic wound healing. Biomed Res Int. 2013;2013:389792 

Mehmood N, Hariz A, Fitridge R, Voelcker NH. Applications of modern sensors and wireless technology in effective wound management. Biomed Mater Res B Appl Biomater. 2013 Oct 21. 

McInnes W, Ruzehaji N, Wright N, Cowin AJ, Fitridge R. Venous ulceration contaminated by multi-resistant organisms: larval therapy and debridement. Wound Care. 2013 Oct;22:S27-30.

Briffa TG, Nedkoff LJ, Knuiman MW, Hankey GJ, Norman PE, Hung J, Thompson PL, Hickling S, Bremner A, Sanfilippo FM. Cross vascular risk for first and recurrent hospitalised atherothrombosis determined retrospectively from linked data. BMJ Open 2013;3(11):e003813

Hoier B,Walker, M, Passos, M, Walker P., Green A., Bangsbo J., Askew C., Hellsten Y.  Angiogenic response to passive movement and active exercise in individuals with peripheral arterial disease.  Journal of Applied Physiology.2013: 115(12)1777-1787

Moran CS, Jose RJ, Moxon JV, Roomberg A, Norman PE, Rush C, Korner H, Golledge J. Everolimus limits aortic aneurysm in the apolipoprotein E deficient (ApoE-/-) mouse by down-regulating CCR2+ monocytes. Arteriosclerosis, Thrombosis and Vascular Biology.2013:33 814-821

Golledge J. Targeting chemokines in aortic aneurysm: Could this be key to a novel therapy for a common problem? Arteriosclerosis, Thrombosis and Vascular Biology.2013:33 670-672

Wang Y, Seto SW, Golledge J. Therapeutic effects of renal denervation on renal failure. Current Neurovascular Research.2013:10(2)172-184

Cronin O, Bradshaw B, Iyer V, Cunningham M, Buttner P, Walker PJ, Golledge J. The association of visceral adiposity with cardiovascular events in patients with peripheral artery disease. PLoS ONE.2013:8(12)e82350

Fernando M, Crowther R, Lazzarini P, Sangla K, Cunningham M, Buttner P, Golledge J. Biomechanical characteristics of peripheral diabetic neuropathy: A systematic review and meta-analysis of findings from the gait cycle, muscle activity and dynamic barefoot plantar pressure. Clinical Biomechanics.2013:28(8)831-845

Sahebkar A, Morris DR, Biros E, Golledge J. Association of single nucleotide polymorphisms in the gene encoding platelet endothelial cell adhesion molecule-1 with the risk of myocardial infarction: a systematic review and meta-analysis. Thrombosis Research.2013:132(2)227-33

Fernando ME, Seneviratne RM, Cunningham M, Lazzarini PA, Sangla KS, Tan YM, Buttner PG, Golledge J. Intensive versus conventional glycaemic control for treating diabetic foot ulcers. Cochrane Database of Systematic Reviews.2013:10 CDO10764

Yeap BB, Alfonso H, Hankey GJ, Flicker L, Golledge J, Norman PE, Chubb SAP. Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men. The Health In Men Study. European Journal of Endocrinology.2013:169 401-8

Haigh K, Binder J, Golledge J, Walker PJ. Barriers to screening and diagnosis of peripheral arterial disease by general practitioners. Vascular Medicine.2013:18(6)325-30

Krishna SM, Dear A, Craig JM, Norman PE, Golledge J. The potential role of homocysteine mediated DNA-methylation and associated epigenetic changes in abdominal aortic aneurysm formation. Atherosclerosis.2013:228(2)295-305

Wong YYE, Golledge J, Flicker L, KierMcCaul KA, Hankey GJ, van Bockxmeer F, Yeap BB,  Norman PE. The association of plasma homocysteine with abdominal aortic aneurysm and aortic diameter: the Health In Men Study. Journal of Vascular Surgery.2013:58(2)364-70

Golledge J, Kuivaniemi H. Genetics of abdominal aortic aneurysm. Current Opinion in Cardiology.2013:28(3)290-296

Yeap BB, Alfonso H, Chubb SAP, Handelsman DJ, Hankey GJ, Golledge J, Flicker L, Norman PE. Lower plasma testosterone or dihydrotesterone, but not estradiol, are associated with symptoms of intermittent claudication in older men. Clinical Endocrinology.2013:79(5)725-732

Golledge J, Clancy P, Hankey GJ, Norman PE. Relationship between serum thrombospondin-2 and cardiovascular mortality in older men. American Journal of Cardiology.2013:111(12)1800-4

Krishna SM, Golledge J. The role of thrombospondin-1 in cardiovascular health and pathology. International Journal of Cardiology.2013:168(2)692-706

Jones GT, Bown MJ, Gretarsdottir S, Romaine S, Helgadottir A, Yu G, Tromp G, Norman PE, Jin C, Baas AF, Blankensteijn JD, Kullo IJ, Phillip LV, Williams MJA, Topless R, Merriman TR, Vasudevan TM, Lewis DR, Blair RD, Hill AA, Sayers RD, Powell JT, Deloukas P, Thorleifsson G, Matthiasson SE, Thorsteinsdottir U, Golledge J, Ariëns RA, Johnson A, Sohrabi S, Scott JD, Carey DJ, Erdman R, Elmore JR, Kuivaniemi H, Samani NJ, Stefansson K, van Rij AM. A sequence variant associated with Sortilin-1 (SORT1) on 1p13.3 is independently associated with Abdominal Aortic Aneurysm. Human Molecular Genetics.2013:22(14)2941-7

Reznik JE, Milanese S, Golledge J, Biros E, Gordon SJ, Galea MP. Extracorporeal shock wave therapy as a treatment for heterotopic ossification: a meta-analysis of published data. Physical Therapy Reviews.2013:18(4)300-7

Haigh K, Golledge J, Bingley JA, Walker PJ. Peripheral arterial disease: Screening in general practice. Australian Family Physician.2013:42(6)391-5

Clancy P, Seto SW, Koblar SA, Golledge J. Role of the angiotensin converting enzyme 1/angiotensin II/angiotensin receptor 1 axis in interstitial collagenase expression in human carotid atheroma. Atherosclerosis.2013:229(2)331-7

Wang Y, Denton K, Golledge J.Control of salt and volume retention cannot be ruled out as a mechanism underlying the blood pressure-lowering effect of renal denervationHypertension Research.2013:36(11)1006-7

Golledge J. Is there a new target in the renin-angiotensin system for aortic aneurysm therapy? Arteriosclerosis, Thrombosis and Vascular Biology.2013:33(4)670-2

Cronin O, Morris D, Walker PJ, Golledge J. The association of obesity with cardiovascular events in patients with peripheral artery disease. Atherosclerosis.2013:228(2)316-23

Bradley DT, Hughes AE, Badger SA,  Jones GT,  Harrison SC, Wright BJ,  Bumpstead S, Baas AF, Gretarsdottir S,  Burnand K,  Child AH,  Clough RE,  Cockerill G,  Hafez H,  Scott DJA,  Ariëns RAS,  Johnson A,  Sohrabi S,  Smith A,  Thompson MW,  van Bockxmeer FM,  Waltham M,  Matthiasson SE,  Thorleifsson G,  Thorsteinsdottir U, Blankensteijn JD,  Teijink JAW,  Wijmenga C,  de Graaf J,  Kiemeney LA,  Wild JB,  Edkins S,  Gwilliam R, Hunt SE,  Potter S,  Lindholt JS,  MD, Golledge J,  Norman PE,  van Rij A,  Powell JT,  Eriksson P,  Stefansson K,  Thompson JR, Humphries SE, Sayers RD,  Deloukas P,  Samani NJ,  Bown MJ. A variant in LDLR is associated with abdominal aortic aneurysm. Circulation: Cardiovascular Genetics.2013:6(5)498-504

Golledge J, Clancy P, Yeap BB, Hankey GJ, Norman PE. Increased serum angiopoietin-2 is associated with abdominal aortic aneurysm prevalence and cardiovascular mortality in older men. International Journal of Cardiology.2013:167(4)1159-63

Golledge J, Cronin O, Iyer V, Bradshaw B, Moxon JV, Cunningham M. Body mass index is inversely associated with mortality in patients with peripheral vascular disease. Atherosclerosis.2013:229(2)549-55

Au TB, Golledge J, Walker PJ, Haigh K, Nelson MR. Peripheral artery disease: Diagnosis and management in general practice. Australian Family Physician.2013:42(6)397-400

Wang Y, Krishna S, Golledge J. The calcium chloride-induced rodent model of abdominal aortic aneurysm. Atherosclerosis.2013:226(1)29-39

Wang Y, Tikellis C, Thomas M, Golledge J. Angiotensin Converting Enzyme 2 and atherosclerosis. Atherosclerosis.2013:226(1)3-8

Seto SW, Krishna SM, Yu H, Liu D, Khosla S, Golledge J. Impaired acetylcholine-induced endothelium-dependent aortic relaxation by caveolin-1 in angiotensin II-infused apolipoprotein-E (ApoE-/-) knockout mice. PLoS ONE.2013:8(3)e58481

Wang Y, Golledge J. Neuronal nitric oxide synthase and sympathetic nerve activity in neurovascular and metabolic systems. Current Neurovascular Research.2013:10(1)81-89

Almeida OP, Hankey GJ, Yeap BB, Golledge J, McCaul K, Flicker L. A risk table to assist health practitioners assess and prevent the onset of depression in later life. Preventative Medicine.2013:57(6)878-82

Wang Y, Krishna S, Walker PJ, Norman P, Golledge J. Transforming growth factor-β and abdominal aortic aneurysm. Cardiovascular Pathology.2013:22(2)126-32

Cronin O, Walker PJ, Golledge J. The association of obesity with abdominal aortic aneurysm presence and growth. Atherosclerosis.2013:226(2)321-7

Dear AE. Incretin Based Therapeutics: Connections to Vascular Biology and Implications for Potential Cardiovascular Disease Prevention. Cardiovascular Drugs and Therapy2013:27 363-4

Hyde Z, Mylankal KJ, Hankey GJ, Flicker L, Norman PE. Peripheral arterial disease increases the risk of subsequent hip fracture in older men. The Health In Men Study. Osteopor Int 2013: 24:1683-8.

 

Norman PE, Curci JA. Understanding the effects of tobacco smoke on the pathogenesis of aortic aneurysm. Arterioscler Thromb Vasc Biol 2013;33 1473-7.

Briffa TG, Nedkoff LJ, Knuiman M, Norman PE, Hung J, Hankey GJ, Thompson PL, Geelhoed E, Hickling S, Sanfilippo FM, Bremner A, Hobbs MST. Downward trend in the prevalence of hospitalisation for atherothrombotic disease. Int J Cardiol. 2013: 164-185 92

Yeap BB, Alfonso H, Chubb SAP, Handelsman DJ, Hankey, Flicker L, Norman PE. Testosterone, dihydrotestosterone and estradiol are differentially associated with lower limb claudication in older men. Clin Endo 2013;79:725-32. 

Wong YYE, Flicker L, Yeap BB, McCaul KA, Hankey GJ, Norman PE. Is hypovitaminosis D associated with abdominal aortic aneurysm, and is there a dose-response relationship? Eur J Vasc Endovasc Surg 2013; 45:657-64. 

Fowkes FGF Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UKA, Williams LJ, Mensah G, Criqui MH. Global Estimates of Prevalence and Risk Factors for Peripheral Artery Disease: Systematic Analysis comparing High-Income and Low and Middle-Income Countries in 2000 and 2010. Lancet 2013;9901:1329-40. 

Wilson WR, Fitridge RA, Weekes AJ, Morgan C, Tavella R, Beltrame JF. Quality of life of patients with peripheral arterial disease and chronic stable angina. Angiology. 2012 Apr;63:223-8. 

Ruzehaji N, Grose R, Krumbiegel D, Zola H, Dasari P, Wallace H, Stacey M, Fitridge R, Cowin AJ. Cytoskeletal protein Flightless (Flii) is elevated in chronic and acute human wounds and wound fluid: neutralizing its activity in chronic but not acute wound fluid improves cellular proliferation. Eur J Dermatol. 2012 Nov-Dec;22:740-50.

Mortensen SP, Askew CD, Walker M, Nyberg M, Hellsten Y. The hyperaemic response to passive leg movement is dependent on nitric oxide; a new tool to evaluate endothelial nitric oxide function.  Physiol.2012: 590(17)4391-400. doi: 10.1113/jphysiol.2012.235952

Moxon JV, Emeto TI, Golledge J. Further evidence to support a role for urocortin 2 in heart failure. The Anatolian Journal of Cardiology.2012:12 121-122

Yu-Ching C, Anderson CD, Bione S, Keene K, Maguire JM, Nalls M, Rasheed A, Zeginigg M, Attia J, Baker R, Barlera S, Biffi A, Bookman E, Brott TG, Brown RD, Chen F, Chen WM, Ciusani E, Cole JW, Cortellini L, Danesh J, Doheny K, Ferrucci L, Franzosi MG, Frossard P, Furie KL, Golledge J, Hankey GJ, Hernandez D, Holliday EG, Hsu FC, Jannes J, Kamal A, Khan MS, Kittner SJ, Koblar SA, Lewis M, Lincz L, Lisa A, Mar M, Moscato P, Mychaleckyj JC, Parati EA, Parolo S, Pugh E, Rost NS, Schallert M, Schmidt H, Scott RJ, Sturm JW, Yadav S, Zaidi M, GARNET Collaborative Research Group, GENEVA Consortium, Boncoraglio GB, Levi CR, Meschia JF, Rosand J, Sale M, Saleheen D, Schmidt R, Sharma P, Worrall B, Mitchell BD; on behalf of the International Stroke Genetics Consortium. Are myocardial infarction-associated single nucleotide polymorphisms associated with ischemic stroke? Stroke.2012:43(4)980-6

Yeap BB, Chubb SAP, McCaul KA, Flicker L, Ho KKY, Golledge J, Hankey GJ, Norman PE. Associations of Insulin-like Growth Factor-I and its binding proteins with abdominal aortic aneurysm and aortic diameter in older men. European Journal of Endocrinology.2012:166(2)191-7

Biros E, Walker PJ, Nataatmadja M, West M, Golledge J. Downregulation of transforming growth factor beta receptor 2 and Notch signaling pathway in human abdominal aortic aneurysm. Atherosclerosis. 2012:220(2)383-6

Ramos-Mozo P, Madrigal-Matute J, Vega de Ceniga M, Blanco-Colio LM, Martinez-Pinna R, Meilhac O, Feldman L, Michel JB, Clancy P, Golledge J, Norman P, Egido J, Martin-Ventura JL. Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm. Atherosclerosis.2012:220(2)552-6

Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng YC, Fornage M, Ikram MA, Malik R, Bevan S, Thorsteinsdottir U, Nalls MA, Longstreth W, Wiggins KL, Yadav S, Parati EA, Destefano AL, Worrall BB, Kittner SJ, Khan MS, Reiner AP, Helgadottir A, Achterberg S, Fernandez-Cadenas I, Abboud S, Schmidt R, Walters M, Chen WM, Ringelstein EB, O'Donnell M, Ho WK, Pera J, Lemmens R, Norrving B, Higgins P, Benn M, Sale M, Kuhlenbäumer G, Doney AS, Vicente AM, Delavaran H, Algra A, Davies G, Oliveira SA, Palmer CN, Deary I, Schmidt H, Pandolfo M, Montaner J, Carty C, de Bakker PI, Kostulas K, Ferro JM, van Zuydam NR, Valdimarsson E, Nordestgaard BG, Lindgren A, Thijs V, Slowik A, Saleheen D, Paré G, Berger K, Thorleifsson G; The Australian Stroke Genetics Collaborative (Golledge J named member), Wellcome Trust Case Control Consortium 2 (WTCCC2), Hofman A, Mosley TH, Mitchell BD, Furie K, Clarke R, Levi C, Seshadri S, Gschwendtner A, Boncoraglio GB, Sharma P, Bis JC, Gretarsdottir S, Psaty BM, Rothwell PM, Rosand J, Meschia JF, Stefansson K, Dichgans M, Markus HS; on behalf of the International Stroke Genetics Consortium . Genetic Risk Factors for Ischaemic Stroke and its Subtypes (the METASTROKE Collaboration): A Meta-analysis of Genome-Wide Association Studies. Lancet Neurology.2012: 11 951-62

Bisoendial RJ, Tanck MW, Golledge J, Broekhuizen LN, Legemate DA, Stroes ESG, Norman PE. The association between the gene encoding 5-lipoxygenase activating protein and abdominal aortic aneurysm. Atherosclerosis.2012:220(2)425-8

Crowther RG, Leicht AS, Spinks WL, Sangla K, Quigley F, Golledge J. Effects of a 6 month exercise program on submaximal walking economy in patients with peripheral arterial disease. Vascular Health and Risk Management.2012:8 225-32

Quirk F, Dickinson C, Baune B, Leicht A, Golledge J. Pilot Trial of Motivational Interviewing in Patients with Peripheral Artery Disease. International Angiology.2012:31(5)468-73

Wright L, Hill KM, Bernhardt J, Lindley R, Ada L, Bajorek BV, Barber PA, Golledge J, Gustafsson L, Hersh D, Kenardy J, Perry L, Middleton S, Brauer SG, Nelson MR. Stroke Management – updated recommendations for treatment along the care continuum. Internal Medicine Journal.2012:42(5)562-69

Subramanian V, Golledge J, Ijaz T, Bruemmer D, Daugherty A. Regulation of PPARγ by angiotensin II via TGF-β1 activated p38 MAP Kinase in aortic smooth muscle cells. Arteriosclerosis, Thrombosis and Vascular Biology.2012:32(2)397-405

Morris DR, Moxon JV, Biros B, Krishna SM, Golledge J. Meta-analysis of the association between transforming growth factor-beta polymorphisms and complications of coronary heart disease. Plos One.2012:7(5)e37878

Holliday EG, Maguire JM, Evans T-J, Koblar S, Jannes J, Sturm JW, Hankey GJ, Baker R, Golledge J, Parsons MW, Malik R, McEvoy M, Biros E, Lewis MD, Lincz LF, Peel R, Oldmeadow C, Smith W, Moscato P, Barlera S, Bevan S, Bis JC, Boerwinkle E, Boncoraglio GB, Brott TG, Brown RD Jr, Cheng Y-C, Cole JW, Cotlarciuc I, Devan WJ, Fornage M, Furie KL, Grétarsdóttir S, Gschwendtner A, Ikram MA, Longstreth WT Jr, Meschia JF, Mitchell BD, Mosley TH, Nalls MA, Parati EA, Psaty BM, Sharma P, Stefansson K, Thorleifsson G, Thorsteinsdottir U, Traylor M, Verhaaren BFJ, Wiggins KL, Worrall BB, The Australian Stroke Genetics Collaborative, The International Stroke Genetics Consortium, The Wellcome Trust Case Control Consortium 2, Sudlow C, Rothwell PM, Farrall M, Dichgans M, Rosand J, Markus HS, Scott RJ, Levi C, Attia J. Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nature Genetics.2012:44(10)1147-1151

Koole D, Hurks R, Schoneveld A, Vink A, Golledge J, Moran CS, de Kleijn DPV, van Herwaarden JA, de Vries JPPM, Laman JD, Huizinga R, Pasterkamp G, Moll FL. Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease. Arteriosclerosis, Thrombosis and Vascular Biology.2012:32(6)1497-504

Krishna SM, Seto SW, Moxon J, Rush C, Walker P, Norman P, Golledge J. Fenofibrate increases high density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. American Journal of Pathology.2012:181(2)706-18

Sherer EA, Bies RR, Clancy P, Norman PE, Golledge J. Growth of screen-detected abdominal aortic aneurysms in men: A Bayesian analysis. CPT: Pharmacometrics & Systems Pharmacology.2012:1 e12

Beiles C, Bourke B, Thomson I. Results from the Australasian Vascular Surgical Audit: the inaugural yearans_5987 105.ANZ Surg .2012: 82 105–111.

Bourke B. The Australasian Vascular Audit: where there is a web, there is a way. ANZ Surg.2012: 82 100–101.

Bourke B, Beiles C, Thomson I, Grigg M, Fitridge R. Development of the Australasian Vascular Surgical Audit. Vasc Surg 2012: 55:164-70.

Davidson PM, Mitchell JA, DiGiacomo M, Inglis SC, Newton PJ, Daly J. Cardiovascular disease in women: implications for improving health outcomes. Collegian. 2012: 19(9)13.  

Hyde Z, Norman PE, Flicker L, Hankey GJ, Almeida OP, McCaul KA, Chubb SAP, Yeap BB. Low free testosterone predicts mortality from cardiovascular disease, but not other causes: a population-based study. Clin Endocrinol Metabol 2012: 97 179-89.

Inglis SC, Du H, Newton PJ, DiGiacomo M, Omari A, Davidson PM. Interventions to improve self-management for lower-limb peripheral arterial disease (Cochrane Review Protocol). Cochrane Database of Systematic Reviews, 2012, Issue 3.

Inglis SC, Lewsey JD, Chandler D, Byrne DS, Lowe GDO, MacIntyre K.Sex-specific temporal trends in first admission to hospital for peripheral artery disease in Scotland 1991-2007.British Journal of Surgery 2012: 99 680-687.

Yeap BB, Chubb SAP, Flicker L, McCaul KA, Ebeling PR, Hankey GJ, Beilby JP, Norman PE. Associations of total osteocalcin with all-cause and cardiovascular mortality in older men. The Health In Men Study. Osteoporosis International 2012:23 599-606.

 

Almeida OP, Alfonso H, Flicker L, Hankey GJ, Norman P. Cardiovascular disease, depression and mortality: The Health In Men Study. Am J Ger Psychiatry 2012;20:433-40.

Ferguson CD, Buettner PG, Golledge J. A meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion. Journal of Vascular Surgery.2011:53(5)1452-3

Parr A, Jayaratne C, Buttner P, Golledge J. Comparison of volume and diameter measurement in assessing small abdominal aortic aneurysm expansion examined using computed tomographic angiography. European Journal of Radiology.2011:79(1)42-47

Trollope A, Moxon JV, Moran CS, Golledge J. Animal models of abdominal aortic aneurysm and their role in furthering management of human disease. Cardiovascular Pathology.2011:20(2)114-123

Golledge J, Muller R, Clancy P, McCann M, Norman PE. Evaluation of the diagnostic and prognostic value of plasma D-dimer for abdominal aortic aneurysm. European Heart Journal.2011:32(3)354-364

Belch J, Hiatt WR, Baumgartner I, Driver IV, Norgren L, Van Belle E, on behalf of the TAMARIS Committees and Investigators (J. Golledge named investigator). Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. The Lancet.2011:377 1929-37

Pal SN, Golledge J. Osteo-progenitors in vascular calcification. Journal of Atherosclerosis and Thrombosis.2011:18(7)551-9

Golledge J, Mallat Z, Tedgui A, Norman PE. Serum secreted phospholipase A2 is associated with abdominal aortic aneurysm presence but not progression. Atherosclerosis.2011: 200-230

Golledge J, Shi G-P, Norman PE. Pathogenesis of aortic aneurysm. Mechanisms of Vascular Disease: A Textbook for Vascular Surgeons.2011: 200-230

Baune BT, Unwin SJ, Quirk F, Golledge J. Neuropsychiatric symptoms in patients with aortic aneurysms. PLoS One.2011:6(7)e22632

Pal S, Clancy P, Golledge J. Circulating concentrations of stem cell mobilizing cytokines are associated with levels of osteo-progenitor cells and aortic calcification severity. Circulation Journal.2011:75(5)1227-34

Norman PE, Muller J, Golledge J. The cardiovascular and prognostic significance of the infra-renal aortic diameter. Journal of Vascular Surgery.2011:54(6)1817-20

Biros E, Norman PE, Jones GT, van Rij AM, Yu G, Moxon JV, Blakensteijn JD, van Sterkernburg SM, Morris D, Baas AF. Golledge J. Meta-analysis of the association between single nucleotide polymorphisms in TGF-β receptor genes and abdominal aortic aneurysm. Atherosclerosis.2011:219(1)218-23

Palamuthusingam D, Quigley F, Golledge J. Implications of the finding of no significant carotid stenosis based on data from a regional Australia vascular unit. Annals of Vascular Surgery.2011:25(8)1050-6

Parr A, McCann M, Bradshaw B, Shahzad A, Buttner P, Golledge J. Thrombus volume is associated with cardiovascular events and aneurysm growth in patients who have abdominal aortic aneurysms. Journal of Vascular Surgery.2011:53(1)28-35

Golledge J, Biros E, Warrington N, Jones GT, Cooper M, van Rij AM, Palmer LJ, Norman PE. A population-based study of polymorphisms in genes related to sex hormones and abdominal aortic aneurysm. European Journal of Human Genetics.2011:19(3)363-366

Leicht AS, Crowther RG, Muller R, Golledge J. The effects of including quality of life responses in models to predict walking performance of patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery.2011: 41(4)511-517

Emeto TI, Moxon JV, Rush C, Woodward L, Golledge J. Relevance of urocortins to cardiovascular disease. Journal of Molecular and Cellular Cardiology.2011:51(3)299-307

Ferguson CD, Buettner PG, Golledge J. Statins and abdominal aortic aneurysm expansion. Journal of Vascular Surgery.2011:53(3)299-307

Trollope A, Golledge J. Angiopoietins, abdominal aortic aneurysm and atherosclerosis. Atherosclerosis.2011:214((2)237-243

Golledge J, Clancy C, Maguire J, Lincz L, Koblar S. The role of Tenascin C in cardiovascular disease. Cardiovascular Research.2011:92(1)19-28

Moxon JV, Padula MP, Clancy P, Emeto TI, Herbert BR, Norman PE, Golledge J. Proteomic analysis of intra-arterial thrombus secretions reveals a negative association of clusterin and thrombospondin-1 with abdominal aortic aneurysm. Atherosclerosis.2011:219(2)432-9

Biros E, Norman PE, Walker PJ, Nataatmadja M, West M, Golledge J. A single nucleotide polymorphism in exon 3 of the kallikrein 1 gene is associated with large but not small abdominal aortic aneurysm. Atherosclerosis.2011:217((2)452-7

Ahimastos AA, Wimberley EP, Buttner PG, Walker PJ, Kingwell BA, Golledge J. A meta-analysis of the outcome of endovascular and non-invasive therapies in the treatment of intermittent claudication. Journal of Vascular Surgery.2011:54(5)1511-21

Golledge J. Carotid atherosclerotic plaque instability: From yesterday to today. European Journal of Vascular and Endovascular Surgery.2011:42 Supplement S39-S40

Bown MJ, Jones GT, Harrison SC, Wright BJ, Bumpstead S, Baas AF, Gretarsdottir S, Badger SA, Bradley DT, Burnand K, Child AH, Clough RE, Cockerill G, Hafez H, Scott DJA, Futers S, Johnson A, Sohrabi S, Smith A, Thompson MM, van Bockxmeer FM, Waltham M, Matthiasson SE, Thorleifsson G, Thorsteinsdottir U, Blankensteijn JD, Teijink JAW, Wijmenga C, de Graaf J, Kiemeney LA, Assimes TL, McPherson R, CARDIoGRAM Consortium, Global BPgen Consortium, DIAGRAM Consortium, VRCNZ Consortium, Folkersen L, Franco-Cereceda A, Palmen J, Smith AJ, Sylvius N, Wild JB, Refstrup M, Edkins S, Gwilliam R, Hunt SE, Potter S, Lindholt JS, Frikke-Schmidt R, Tybjærg-Hansen A, Hughes AE, Golledge J, Norman PE, van Rij A, Powell JT, Eriksson P, Stefansson K, Thompson JR, Humphries SE, Sayers RD, Deloukas P, Samani NJ. Abdominal aortic aneurysm is associated with a variant in the low density lipoprotein receptor Related Protein 1 (LRP1) gene. The American Journal of Human Genetics.2011:89(5)619-27

Leicht AS, Crowther RG, Golledge J. Influence of peripheral arterial disease and supervised walking on heart rate variability. Journal of Vascular Surgery.2011:54(5)1352-9

Golledge J, Norman PE. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis.2011:217(1)57-63

Hyde Z, Norman PE, Flicker L, Hankey GJ, McCaul KA, Almeida OP, Chubb SAP, Yeap BB. Elevated luteinizing hormone predicts ischaemic heart disease events in older men. The Health In Men Study. Eur J Endocrinol 2011;164:569-77.

Yeap BB, Chubb SAP, McCaul KA, Ho KKY, Hankey GJ, Norman PE, Flicker L. Associations of Insulin-like Growth Factor-I and its binding proteins 1 and 3 with all-cause and cardiovascular mortality in older men. The Health In Men Study. Eur J Endocriniol 2011;164:715-23

Holmes MV, Newcombe P, Hubacek JA, Sofat R, Ricketts SL Cooper J, Breteler M, Bautista LE, Sharma P, Whittaker J, Smeeth L, Fowkes FGR, Algra A, Shmeleva V, Szolnoki Z, Roest M, Linnebank M, Zacho J, Nalls MA, Singleton AB, Ferrucci L, Hardy J, Worrall BB, Rich S, Brott TG, Brown Jr. RD, Norman PE, Flicker L, Almeida OP, van Bockxmeer F, Shimokata H, Khaw K-T, Wareham N, Bobak M, Sterne JAC, Davey Smith G, Talmud PJ, van Duijn C, Humphries SE, Price J, Ebrahim S, Lawlor DA, Hankey GJ, Meschia JF, Sandhu MS, Hingorani AD, Casas JP. MTHFR genotype, homocysteine and stroke risk: Investigation of effect modification by population dietary folate based on meta-analysis of genetic studies and randomised clinical trials. Lancet 2011;378:584-94.

Lindholt JS, Norman PE. Screening for abdominal aortic aneurysm reduces operative mortality in men undergoing planned repair. A meta-analysis of five randomised trials. Br J Surg 2011;98:619-22.

Parmenter BJ, Raymond J, Dinnen PJ, Fiatarone Singh MA. A Systematic Review of Randomized Controlled Trials: Walking versus alternative exercise prescription as treatment for intermittent claudication. Atherosclerosis 2011;218(1):1-12.

Nelson MR, Quinn S, Winzenberg TM, Howes F, Shiel L, Reid CM. Principal results of the ankle brachial index determination by oscillometric method in general practice study. HBPRCA ASM Perth 2011.

Norman PE, Spilsbury K, Semmens JB. Falling rates of hospitalisation and mortality from abdominal aortic aneurysms in Australia. Vasc Surg. 2011: 53:274-7.

Beer C, Alfonso H, Flicker L, Norman PE, Hankey GJ, Almeida OP. Traditional risk factors for incident cardiovascular events have limited importance in later life compared with the Health in Men Study Cardiovascular Risk Score. Stroke 2011: 42 952-59

CRP CHD Genetics Collaboration. Is C-reactive protein causally relevant to coronary disease. Mendelian randomization analysis based on individual participant data. BMJ.2011: 342:548doi:10.1136bmj.c1548.

Golledge J. Aortic dissection Coronary Care Manual. 2010: 589-592

Moran CS, Clancy P, Biros E, Blanco-Martin B, McCaskie P, Palmer LJ, Coomans D, Norman PE, Golledge J. Association of PPAR gamma allelic variation, osteoprotegerin and abdominal aortic aneurysm. Clinical Endocrinology.2010:72(1)128-132

Golledge J, van Bockxmeer F, Jamrozik K, McCann M, Norman P. Association between serum lipoproteins and abdominal aortic aneurysm. American Journal of Cardiology.2010:105(10)1480-1484

Magee R, Quigley F, McCann M, Buttner P, Golledge J. Growth and risk factors for expansion of dilated popliteal arteries. European Journal of Vascular and Endovascular Surgery.2010:39(5)606-611

Thompson AR, Cooper JA, Jones GT, Drenos F, van Bockxmeer FM, Biros E, Walker PJ, van Rij AM, Golledge J, Norman PE, Hafez H, Humphries SE. Assessment of the association between genetic polymorphisms in transforming growth factor beta and its binding protein (LTBP) and the presence and expansion of abdominal aortic aneurysm. Atherosclerosis.2010:209(2)367-373

Parr A, Buettner P, Shahzad A, Golledge J. Relationship of infra-renal abdominal aortic calcific deposits and cardiovascular events in patients with peripheral artery disease. American Journal of Cardiology.2010:105(6)895-899

Golledge J, Cullen B, Rush C, Moran C, Secomb E, Wood F, Daugherty A, Campbell J, Norman P. Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm. Atherosclerosis.2010:210(1)51-56

Pal SN, Rush C, Parr A, van Campenhout A, Golledge J. Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. Atherosclerosis.2010:210(1)88-93

Tosenovsky P, Quigley F, Golledge J. Hybrid repair of an aberrant right subclavian artery with Kommerell’s diverticulum. European Journal of Vascular and Endovascular Surgery extra.2010:19(3)e31-e33.

Ferguson C, Clancy P, Bourke B, Walker P, Dear A, Buckenham T, Norman P, Golledge J. Association of statin prescription with small abdominal aortic aneurysm progression. American Heart Journal.2010:159(2)307-313

Golledge J, Biros E, Cooper M, Warrington N, Palmer LJ, Norman PE. Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm. Atherosclerosis.2010:209(2)487-491

Golledge J, Clancy P, Moran C, Biros E, Rush C, Walker P, Norman PE. The novel association of the chemokine CCL22 with abdominal aortic aneurysm. American Journal of Pathology.2010:176(5)2098-2106

Belch JJ, Dormandy J; CASPAR Writing Committee, Biasi BM, Cairols M, Diehm C, Eikelboom B, Golledge J, Jawien A, Lepäntalo M, Norgren L, Hiatt WR, Becquemin JP, Bergqvist D, Clement D, Baumgartner I, Minar E, Stonebridge P, Vermassen F, Matyas L, Leizorovicz A. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. Journal of Vascular Surgery.2010:52(4)825-835

Golledge J, Norman P. Atherosclerosis and abdominal aortic aneurysm: Cause, response or common risk factors? Arteriosclerosis, Thrombosis and Vascular Biology.2010:30(6)1075-1077

Yeap BB, Hyde Z, Norman PE, Chubb SA, Golledge J. Associations of Total Testosterone, Sex Hormone-Binding Globulin, Calculated Free Testosterone, and Luteinizing Hormone with Prevalence of Abdominal Aortic Aneurysm in Older Men. The Journal of Clinical Endocrinology & Metabolism.2010:95(3)1123-1130

Golledge J, Cullen B, Moran C, Rush C. Efficacy of simvastatin in reducing aortic dilatation in mouse models of abdominal aortic aneurysm. Cardiovascular Drugs and Therapy.2010:24(5-6)373-378

Moxon JV, Parr A, Emeto TI, Walker P, Norman PE, Golledge J. Diagnosis and monitoring of abdominal aortic aneurysm: Current status and future prospects. Current Problems in Cardiology.2010:35(10)512-548

Krishna S, Dear A, Norman P, Golledge J. Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysms. Atherosclerosis.2010:212(1)16-29

Biros E, Cooper M, Palmer LJ, Walker PJ, Norman PE, Golledge J. Association of an allele on chromosome 9 and abdominal aortic aneurysm. Atherosclerosis.2010:212(2)539-542

Subramanian V, Golledge J, Ijaz T, Bruemmer D, Daugherty A. Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPARgamma. Circulation Research.2010:107(8)953-958

Dickinson C, Quirk F, Baune B, Leicht A, Golledge J. Quality of life in patients with peripheral arterial disease. Journal of Science and Medicine in Sport.2010:12 127-128

Inglis SC, McMurray JJV, Böhm M, Schaufelberger M, van Veldhuisen DJ, Lindberg M, Dunselman P,  Hjalmarson A, Kjekshus J, Waagstein F, Wedel H, Wikstrand J, on behalf of the CORONA Study Group. Intermittent claudication as a predictor of outcome in patients with ischemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA). European Journal of Heart Failure 2010;12:698-705.

Lakshmanan R, Hyde Z, Jamrozik K, Hankey GJ, Norman PE. Population based observational study of claudication in older men. The Health In Men Study. Med J Aust. 2010;192:641-5.

Nelson M, Reid C, Winzenberg T, Quinn S, Howes F. Ankle brachial index determination by  oscillometric method in general practice (ABIDING). WONCA World Conference of Family Doctors, Cancun Mexico 2010.

Norman PE, Powell JT. Site specificity of aneurysmal disease. Circulation. 2010;121:560-8.

Norman PE, Schoen DE, Gurr JM, Kolybaba ML. High rates of amputation amongst Indigenous people in Western Australia. (Research Letter) MJA. 2010;192:421.

Parmenter BJ, Raymond J, Fiatarone Singh M. The Effect of Exercise on Haemodynamics in Intermittent Claudication: A Systematic Review of Randomized Controlled Trials. Sports Med 2010;40(5):433-47.

Yeap BB, Chubb SAP, Ebeling PR, McCaul KA, Beilby JP, Flicker L, Norman PE. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia and triglyceride levels. Eur J Endocrinol. 2010;163:265-72.

Drew BG, Duffy SJ, Formosa MF, Natoli AK, Henstridge DC, Penfold SA, Thomas WG, Mukhamedova N, de Courten B, Forbes JM, Yap FY, Kaye DM, van Hall G, Febbraio MA, Kemp BE, Sviridov D, Steinberg GR, Kingwell BA. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation. 2009;119:2103-2111.

Golledge J, Clancy P, Jones GT, Cooper M, Palmer LJ, van Rij AM, Norman PE. Assessment of the association between genetic polymorphisms in transforming grow factor beta receptors, serum transforming growth factor beta-1 concentration and abdominal aortic aneurysm. Br J Surg 2009;96:628-32.

Golledge J, Leicht A, Crowther ., Askew C, Gibbs H, Walker P.  Clinical endpoints in peripheral endovascular revascularisation trials: a case for standardized definitions. European Journal of Vascular and Endovascular Surgery, 27(3):497, 2009.

Henstridge DC, Drew BG, Formosa MF, Natoli AK, Cameron-Smith D, Duffy SJ, Kingwell BA. The effect of the nitric oxide donor sodium nitroprusside on glucose uptake in human primary skeletal muscle cells. Nitric Oxide. 2009.

Nelson M, Quinn S, Reid C, Winzenberg T. ABIDING – extending the utility of oscillometric blood pressure devices in general practice. HBPRCA ASM, Sydney 2009

Nelson M, Quinn S, Reid C, Winzenberg T. ANKLE brachial index determination by oscillometric method in general practice (ABIDING). General Practice and Primary Health Care Research Conference, Melbourne 2009.

Nelson MR, Quinn S, Reid CM, Winzenberg T. Ankle brachial index determination by oscillometric method in general practice (ABIDING). Heart Foundation Conference, Brisbane 2009.

Nelson M, Reid C, Winzenberg T, Quinn S, Howes F. Ankle-brachial index determination by oscillometric method in general practice (ABIDING). 8th International Congress on Coronary Artery Disease, Prague, Czech Republic, 2009.

Norman PE, Davis WA, Coughlan MT, Forbes JM, Golledge J, Davis TME. Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study. Vasc Surg 2009;50:626-31.

Patel S, Drew BG, Nakhla S, Duffy SJ, Murphy AJ, Barter PJ, Rye KA, Chin-Dusting J, Hoang A, Sviridov D, Celermajer DS, Kingwell BA. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. Am Coll Cardiol. 2009;53:962-971.

Nedkoff LJ, Briffa TG, Knuiman M, Hung J, Norman PE, Hankey GJ, Thompson PL, Geelhoed E, Sanfilippo FM, Hickling S, Bremner A, Hobbs M. Temporal trends in the incidence and recurrence of hospitalised atherothrombotic disease in an Australian population, 2000 – 2007: data linkage study. Heart 2012;98:1449-56

Vinh A, Gaspari T, Widdop R, Liu HB, Dousha L and Dear AE. A Novel Histone Deacetylase Inhibitor Reduces Abdominal Aortic Aneurism Formation in Angiotensin-II Infused APOE Deficient Mice.  Vasc Res 45:143-152 (2008).

Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham risk score in prediction of cardiovascular events and mortality in 16 international cohort studies. JAMA 2008;300:197-208.

Golledge J, Karan M, Moran C, Muller J, Clancy P, Dear A, Norman PE. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart.2008;29:665-72.

Golledge J, Tsao PS, Dalman RL, Norman PE. Circulating markers of abdominal aortic aneurysm presence and progression. Circulation 2008;118:2382-92.

 Jones GT, Thompson AR, van Bockxmeer FM, Hafez H, Cooper J, Golledge J, Humphries SE, Norman PE, van Rij AM. The Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler Thromb Vasc Biol 2008;28:764-70.

Jordan SC, Vo A A, Reinsmoen N L. Angiotensin II Blockade in Marfan’s Syndrome. The New England Journal of Medicine. 2008;359:1732-1734.

Smallwood L, Allcock R, van Bockxmeer F, Warrington N, Palmer LJ, Iacopetta B, Golledge J, Norman PE. Polymorphisms of the MMP-9 gene and abdominal aortic aneurysm. Br J Surg 2008;95:1239-44.

Golledge J, Clancy P, Jamrozik K, Norman PE. Obesity, adipokines and abdominal aortic aneurysm. Health In Men Study. Circulation 2007;116:2275-79.

Golledge J, Muller J, Shephard N, Clancy P, Smallwood L, Moran C, Dear AE, Palmer LJ, Norman PE. Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2007;27:655-660.

Green S, Askew CD, Walker PJ. Effect of type II diabetes mellitus on exercise tolerance and the physiological response to exercise in peripheral arterial disease. Diabetologia. 2007;50(4): 859-866.

Le MT, Jamrozik K, Davis TME, Norman PE. Negative association between infra-renal aortic diameter and glycaemia: The Health In Men Study. Eur J Vasc Endovasc Surg 2007;33:599-604.

Norman PE, Powell JT. Abdominal aortic aneurysm: the prognosis in women is worse than in men. Circulation. 2007;115:2865-69.

Golledge, J.; Askew, C.D.; Leicht, A.; Oldenburg, B. Outcome assessment for intermittent claudication - letter. European Journal of Vascular and Endovascular Surgery.2006;31(1):44-45.

Hankey GJ, Norman PE, Eikelboom JW. Medical management of peripheral arterial disease. JAMA 2006;295:547-553.

Sanderson B, Askew C, Stewart I, Walker P, Gibbs H, Green S.  Short-term effects of cycle and treadmill training on exercise tolerance in peripheral arterial disease. Journal of Vascular Surgery.2006;44:119-127.

Wood RE, Sanderson B, Askew CD, Walker PJ, Green S, Stewart I.  The effect of training on the response of plasma vascular endothelial growth factor to exercise in patients with peripheral arterial disease. Clinical Science. 2006; 111: 401-409.

Askew CD, Green S, Walker PJ, Kerr GK, Green A, Williams A, Febbraio M.  Muscle phenotype is associated with exercise tolerance in peripheral arterial disease. Journal of Vascular Surgery. 2005;41(5): 802-807.

Henstridge D C, Kingwell B A, Formosa M F, Drew B G, McConell G K, Duffy S J. Effects of the nitric oxide donor, sodium nitroprusside, on resting leg glucose uptake in patients with type 2 diabetes.  Diabetologia. 2005;48:2602-2608.

Moran CS, McCann M, Karan M, Norman PE, Ketheesan N, Golledge J. Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation 2005;111:3119-3125.

Norman PE, Davis WA, Bruce DG, Davis TME. Peripheral arterial disease and risk of cardiac death in type 2 diabetes: The Fremantle Diabetes Study. Diabetes Care. 2006;29:575-580.

Norman PE, Powell JT. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol. 2005;25:39-46.

Laurvick CL, Norman PE, Semmens JB, Hobbs MST. Population-based study of carotid endarterectomy in Western Australia. Br J Surg. 2004;91:168-73.

Norman P, Le MTQ, Pearce C, Jamrozik K. Infra-renal aortic diameter predicts all-cause mortality. Arterioscler Thromb Vasc Biol. 2004;24:1278-82.

Norman P, Spencer CA, Lawrence-Brown MM, Jamrozik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation. 2004;110:862-6.

Norman PE, Jamrozik K, Lawrence-Brown M, Le M, Spencer C, Tuohy T, Parsons R, and Dickinson J. Impact of screening on mortality from abdominal aortic aneurysm: results of a large, population-based randomised controlled trial. BMJ. 2004;329:1259-62.

Kingwell BA, Formosa M, Muhlmann M, Bradley SJ, McConell GK. Type 2 diabetic individuals have impaired leg blood flow responses to exercise: Role of endothelium-dependent vasodilation. Diabetes Care. 2003;26:899-904.

Norman PE, Semmens J, Laurvick C, Lawrence-Brown M. Long-term relative survival in elderly patients following carotid endarterectomy: A population based study. Stroke 2003;34:e95-e98.

Askew CD, Green S, Walker PJ, Hou X-Y. Physiological and symptomatic responses to incremental cycling and walking in claudicants. Clinical Physiology. 2002; 22(5): 348-355.

Askew CD, Walker PJ, Bourke B, Gibbs H, Swanson C.  An assessment of the predictive value of arterial duplex ultrasound for planning lower extremity vascular reconstruction, compared with additional conventional angiography.  Federal government report; Department of Health and Ageing, November 2002.

Hou X-Y, Green, S, Askew, C.D, Barker, G, Green A, Walker PJ.   Skeletal muscle mitochondrial ATP production rate and walking performance in peripheral arterial disease.  Clinical Physiology. 2002; 22(3): 226-232.

Barker G, Green S, Askew CD, Walker PJ. Effect of propionyl-L-carnitine on exercise performance in peripheral arterial disease. Medicine and Science in Sports and Exercise.2001: 33(9)1415-1422.

Green, S, Askew, C.D. The physiology of walking performance in peripheral arterial disease.  In Muffulli et al. (eds). Sports Medicine for Specific Ages and Abilities; Churchill Livingstone, London, 2001: 385-393.

Semmens, JB, Norman PE, Lawrence-Brown MMD, Holman CDJ. The influence of gender on outcome from ruptured abdominal aortic aneurysm. Br J Surg. 2000;87:191-4.

Bradley SJ, Kingwell BA, McConell GK. Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes. 1999;48:1815-1821.

Norman PE, Semmens JB, Lawrence-Brown MMD, Holman CDJ. Long term relative survival after surgery for Abdominal Aortic Aneurysm in Western Australia: Population based study.  BMJ 1998;317:852-856.